GTS Securities’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-51,607
Closed -$2.42M 1436
2024
Q3
$2.42M Buy
51,607
+10,396
+25% +$488K 0.01% 353
2024
Q2
$2.23M Buy
41,211
+21,934
+114% +$1.18M ﹤0.01% 364
2024
Q1
$1.31M Sell
19,277
-50,095
-72% -$3.41M ﹤0.01% 464
2023
Q4
$4.34M Buy
69,372
+27,866
+67% +$1.74M 0.01% 200
2023
Q3
$1.88M Buy
41,506
+13,908
+50% +$631K ﹤0.01% 342
2023
Q2
$1.55M Buy
+27,598
New +$1.55M 0.05% 317